Rituximab in ankylosing spondylitis: a promising option when other treatments are not viable

Gokten, D. BuluTMercan, R.2025-04-062025-04-0620250392-856X1593-098Xhttps://hdl.handle.net/20.500.11776/17286[No abstract available]eninfo:eu-repo/semantics/closedAccessTherapyPatientRituximab in ankylosing spondylitis: a promising option when other treatments are not viableLetter433548549Q2WOS:0014453657000222-s2.0-10500023436939625821Q2